투과형 엑스선 회절 분석시스템용 시료 지지장치 및 이를 이용한 투과형 엑스선 회절 분석시스템
    4.
    发明授权
    투과형 엑스선 회절 분석시스템용 시료 지지장치 및 이를 이용한 투과형 엑스선 회절 분석시스템 有权
    用于X射线衍射分析系统和透射型X射线衍射分析系统的样品支撑装置

    公开(公告)号:KR101793250B1

    公开(公告)日:2017-11-02

    申请号:KR1020160041693

    申请日:2016-04-05

    Abstract: 투과형엑스선회절분석시스템용시료지지장치및 이를이용한투과형엑스선회절분석시스템이개시된다. 본발명의일 실시예에따른투과형엑스선회절분석시스템용시료지지장치는수평방향으로배치되는제1 지지프레임; 제1 지지프레임의상부에배치되어제1 지지프레임에의해지지되되, 단열기능을가지는본체부와본체부를관통하되시료가수용된쿼츠캐필러리(quartz capillary)가삽입되는쿼츠튜브(quartz tube)와쿼츠튜브와쿼츠캐필러리사이에배치되는히팅코일을구비하여시료를가열하고시료의열적평형상태를유지하게하는퍼니스; 및제1 지지프레임의양단부에각각착탈가능하게결합되되, 캐리어가스를공급하는가스공급관과쿼츠튜브의일단부를상호연통되게연결하고캐리어가스를배출하는가스배출관과쿼츠튜브의타단부를상호연통되게연결하는가스관연결부를포함한다.

    Abstract translation: 公开了用于透射型X射线衍射分析系统的样品支持装置和使用该装置的透射型X射线衍射分析系统。 根据本发明实施例的用于透射X射线衍射分析系统的样品支撑设备包括:第一支撑框架,沿水平方向布置; 第一doedoe被放置在由第一支撑框架支持的支承框架的顶部,但通过具有热绝缘功能和主体石英样品的主体部分的部分被容纳毛细管(石英毛细管)被插入石英管(石英管),和 具有石英管和设置在石英毛细管之间的加热线圈以加热样品并保持样品的热平衡状态的炉; Mitje doedoe每个可拆卸地联接到所述框架的两端部的第一支撑,以连接在气体供给管的一端,用于与所述气体出口管的另一端和用于排出所述载气的石英管供给所述载气部分的相互通信和相互通信的石英管的连接 和一个气体管道连接部分。

    경화된 β-사이클로덱스트린 중합체 분말과 그의 제조방법
    5.
    发明授权
    경화된 β-사이클로덱스트린 중합체 분말과 그의 제조방법 失效
    聚合β-环糊精粉及其制备方法

    公开(公告)号:KR100785913B1

    公开(公告)日:2007-12-17

    申请号:KR1020060119300

    申请日:2006-11-29

    Abstract: A cured beta-cyclodextrin polymer powder, its preparation method, and a filler for a solid phase extraction containing the cured beta-cyclodextrin polymer powder are provided to extract a steroid hormone present in a living body sample simply and effectively by using the cured beta-cyclodextrin polymer powder. A cured beta-cyclodextrin polymer powder comprises a beta-cyclodextrin polymer prepared by the reaction of a beta-cyclodextrin monomer and epichlorohydrin; and a metal ion which is coated on the surface of the beta-cyclodextrin polymer. Preferably the metal ion is selected from Ca and Na. The cured beta-cyclodextrin polymer powder is prepared by dissolving beta-cyclodextrin in an alkaline aqueous solution and adding epichlorohydrin to it to prepare a beta-cyclodextrin polymer of gel state; dipping the polymer in a metal salt aqueous solution to coat the polymer with a metal ion, thereby preparing a cured beta-cyclodextrin polymer; and washing, drying and pulverizing the obtained polymer.

    Abstract translation: 提供固化的β-环糊精聚合物粉末,其制备方法和用于固相β-环糊精聚合物粉末的固相提取填料,通过使用固化的β-环糊精聚合物粉末提取活体样品中存在的类固醇激素, 环糊精聚合物粉末。 固化的β-环糊精聚合物粉末包含通过β-环糊精单体和表氯醇反应制备的β-环糊精聚合物; 以及涂覆在β-环糊精聚合物表面上的金属离子。 优选地,金属离子选自Ca和Na。 固化的β-环糊精聚合物粉末通过将β-环糊精溶解在碱性水溶液中并加入表氯醇来制备凝胶状态的β-环糊精聚合物来制备; 将聚合物浸渍在金属盐水溶液中以用金属离子涂覆聚合物,从而制备固化的β-环糊精聚合物; 并洗涤,干燥和粉碎所得聚合物。

    리튬이차전지용 나노복합체의 제조 방법
    6.
    发明公开
    리튬이차전지용 나노복합체의 제조 방법 无效
    锂二次电池纳米复合材料的制备方法

    公开(公告)号:KR1020130102827A

    公开(公告)日:2013-09-23

    申请号:KR1020120023965

    申请日:2012-03-08

    Abstract: PURPOSE: A manufacturing method of a nanocomposite is provided to manufacture a nanocomposite with improved stability, electrode capacity, and cycle performance by modifying the surface of a LiMO2-based electrode active material in a lamellar structure. CONSTITUTION: A manufacturing method of a nanocomposite comprises a step of dispersing a LiMO2-based positive active material into a dispersing medium; a step of adding monomers of a conductive polymer into the dispersion; and a step of conducting a polymerization reaction by adding an oxidant into the dispersion and washing and drying the product. M is selected from Ni, Co, Mn, Al, Sr, Cu, Fe, Mg, B, or Ga. The dispersion medium is selected from ethanol, butanol, acetonitrile, or a mixture thereof.

    Abstract translation: 目的:提供纳米复合材料的制造方法,通过改变层状结构中的基于LiMO 2的电极活性材料的表面来制造具有改善的稳定性,电极容量和循环性能的纳米复合材料。 构成:纳米复合材料的制造方法包括将LiMO 2基正极活性物质分散到分散介质中的步骤; 将导电性聚合物的单体添加到分散体中的工序; 以及通过向分散体中加入氧化剂并洗涤和干燥产物进行聚合反应的步骤。 M选自Ni,Co,Mn,Al,Sr,Cu,Fe,Mg,B或Ga,分散介质选自乙醇,丁醇,乙腈或其混合物。

    지리산오갈피 추출물 또는 이로부터 분리한 리그난계화합물을 유효성분으로 함유하는 항암제 보조용 약학적조성물
    7.
    发明公开
    지리산오갈피 추출물 또는 이로부터 분리한 리그난계화합물을 유효성분으로 함유하는 항암제 보조용 약학적조성물 无效
    含有ACANTHOPANAX CHIISANENSIS或LIGNAN化合物的药物组合物从其分离用于抗原剂助剂

    公开(公告)号:KR1020080098814A

    公开(公告)日:2008-11-12

    申请号:KR1020070044150

    申请日:2007-05-07

    Abstract: A pharmaceutical composition for aidding anti-cancer drug is provided to suppress CYP3A4 enzyme engaging in a metabolism of the anti-cancer drug by comprising a Jirisan Aralia extract or a lignan based compound separated from the Jirisan Aralia extract as an active ingredient, to enhance a concentration in blood of the anti-cancer drug, to reduce a side effect according to an excessive medication of the anticancer medicine and to exhibit an excellent drug effect. A Jirisan Aralia extract is manufactured by extracting Jirisan Aralia using water, an alcohol or a mixed solvent thereof. The alcohol is a methanol or an ethanol. A lignan based compound is obtained by refining the Jirisan Aralia extract. A pharmaceutical composition for aidding anti-cancer drug is manufactured by comprising the Jirisan Aralia extract or the lignan based compound separated from the Jirisan Aralia extract as an active ingredient.

    Abstract translation: 本发明提供了一种药物组合物,其用于抑制抗癌药物的代谢中的CYP3A4酶,其特征在于,含有Jirisan Aralia提取物或从Jirisan Aralia提取物中分离出的木脂素类化合物作为活性成分,以增强抗癌药物的代谢 浓度在抗癌药物的血液中,根据抗癌药物的过量药物减少副作用并显示出优异的药物作用。 Jirisan Aralia提取物通过使用水,酒精或其混合溶剂提取Jirisan Aralia来制造。 醇是甲醇或乙醇。 通过精炼Jirisan Aralia提取物获得木脂素基化合物。 通过包含Jirisan Aralia提取物或从Jirisan Aralia提取物中分离出的木酚素基化合物作为活性成分制造用于启动抗癌药物的药物组合物。

    당귀 추출물 또는 이로부터 분리한 쿠마린계 화합물을 유효성분으로 함유하는 폐암 예방용 조성물
    8.
    发明授权
    당귀 추출물 또는 이로부터 분리한 쿠마린계 화합물을 유효성분으로 함유하는 폐암 예방용 조성물 失效
    用于预防含有作为活性成分的ANGELICA GIGAS NAKAI提取物或基于COUMARA的化合物的肺癌的组合物

    公开(公告)号:KR100829122B1

    公开(公告)日:2008-05-13

    申请号:KR1020060122415

    申请日:2006-12-05

    CPC classification number: A61K31/37 A61K36/232

    Abstract: A composition comprising the extract of Angelica gigas Nakai or coumarin based compounds isolated therefrom is provided to inhibit activity of CYP2A6 enzyme as a major enzyme causing lung cancer, so that the composition is useful for prevention of lung cancer. A composition for prevention of lung cancer comprises the extract of Angelica gigas Nakai or coumarin based compounds isolated therefrom represented by the formula(1) or formula(2) wherein R1 is hydroxyl group or C2-C10 alkenylcarbonyloxy group; R2 and R3 are each independently hydrogen, C1-C5 alkyl group or C1-C5 alkyl group having hydroxyl group; R4 is hydrogen, C1-C5 alkoxy or C2-C5 alkenyloxy group; n is 0 or 1; and R5 is linear or branched C2-C10 alkenyl group, wherein the coumarin based compounds include decursin represented by the formula(3), decursinol angelate represented by the formula(5), 7-dimethyl suberosine represented by the formula(6) or isoimperatorin represented by the formula(7).

    Abstract translation: 提供了包含从其中分离出的当归提取物或基于香豆素的化合物的组合物以抑制CYP2A6酶作为引起肺癌的主要酶的活性,使得该组合物可用于预防肺癌。 用于预防肺癌的组合物包括由式(1)或式(2)表示的其中R 1为羟基或C 2 -C 10烯基羰基氧基的分离自其的分离的当归粉末或香豆素基化合物的提取物; R2和R3各自独立地为氢,C1-C5烷基或具有羟基的C1-C5烷基; R4是氢,C1-C5烷氧基或C2-C5烯氧基; n为0或1; 其中所述香豆素类化合物包括由式(3)表示的前胡素,由式(5)表示的当归酸前胡酯,由式(6)表示的7-二甲基异亮氨酸或异精氨酸 由式(7)表示。

    경화된 β-사이클로덱스트린 중합체 분말을 이용한스테로이드 화합물의 선택적 추출방법
    9.
    发明授权
    경화된 β-사이클로덱스트린 중합체 분말을 이용한스테로이드 화합물의 선택적 추출방법 有权
    选择性提取方法使用聚合β; -CYCLODEXTRIN粉末的甾体HORMONES

    公开(公告)号:KR100817934B1

    公开(公告)日:2008-03-31

    申请号:KR1020060119299

    申请日:2006-11-29

    CPC classification number: C07J75/00

    Abstract: A selective extraction method of a steroid compound using polymerized beta-cyclodextrin is provided to extract various shapes of the steroid hormones from a biological sample effectively through a simple process. A selective extraction method of a steroid compound using polymerized beta-cyclodextrin powder comprises the steps of: adding buffer solution and hydrolase to a liquid sample including the steroid compound; removing a water layer by centrifugation after adding and stirring hardened beta-cyclodextrin powder that beta-cyclodextrin monomer forms a layer structure by being bridged-bonded by epichlorohydrin and metal ions are spread between the layers of the bridged beta-cyclodextrin polymer to the reaction solution; and extracting the steroid compound by applying organic solvents after adding phosphate buffer solution and polar organic solvents, and controlling pH at a range of 9.0 - 10.0.

    Abstract translation: 提供使用聚合β-环糊精的类固醇化合物的选择性提取方法,通过简单的方法有效地从生物样品中提取各种形状的类固醇激素。 使用聚合的β-环糊精粉末的类固醇化合物的选择性提取方法包括以下步骤:向包含类固醇化合物的液体样品中加入缓冲溶液和水解酶; 通过在加入和搅拌硬化的β-环糊精粉末之后通过离心除去水层,β-环糊精单体通过用表氯醇和金属离子桥接键合形成层结构,在桥连的β-环糊精聚合物层之间铺展到反应溶液 ; 并在加入磷酸盐缓冲液和极性有机溶剂后通过施加有机溶剂萃取类固醇化合物,并控制pH在9.0 - 10.0的范围内。

Patent Agency Ranking